Σύνδρομο Γκιλαίν-Μπαρέ (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Σύνδρομο Γκιλαίν-Μπαρέ" in Greek language version.

refsWebsite

Global rank Greek rank

42nih.gov

4^th place

34doi.org

2^nd place

3^rd place

5web.archive.org

1^st place

3archive.org

6^th place

5^th place

2hrsa.gov

low place

1google.ca

838^th place

220^th place

1gla.ac.uk

2,948^th place

9,155^th place

1minervamedica.it

low place

1oxfordjournals.org

1,389^th place

724^th place

1books.google.com

3^rd place

6^th place

1zenodo.org

621^st place

1,469^th place

archive.org

Yuki, Nobuhiro; Hartung, Hans-Peter (14 June 2012). «Guillain–Barré Syndrome». New England Journal of Medicine 366 (24): 2294–2304. doi:10.1056/NEJMra1114525. PMID 22694000. https://archive.org/details/sim_new-england-journal-of-medicine_2012-06-14_366_24/page/2294.
Ropper, Allan H. (April 23, 1992). «Current Concepts - The Guillain–Barré Syndrome». New England Journal of Medicine 326 (17): 1130–1136. doi:10.1056/NEJM199204233261706. PMID 1552914. https://archive.org/details/sim_new-england-journal-of-medicine_1992-04-23_326_17/page/1130.
Bickerstaff, E.R.; Cloake, P.C. (14 July 1951). «Mesencephalitis and rhombencephalitis.». British Medical Journal 2 (4723): 77–81. doi:10.1136/bmj.2.4723.77. PMID 14848512. PMC 2069534. https://archive.org/details/sim_british-medical-journal_1951-07-14_2_4723/page/77.

books.google.com

Landry, Jean-Baptiste (1859). «Note sur la paralysie ascendante aiguë». Gazette Hebdomadaire de Médecine et de Chirurgie 6: 472–474, 486–488. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-02-27. https://web.archive.org/web/20170227205021/https://books.google.com/books?id=rwxAAAAAcAAJ&pg=PA486.

doi.org

dx.doi.org

Sejvar, James J.; Baughman, Andrew L.; Wise, Matthew; Morgan, Oliver W. (2011). «Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis». Neuroepidemiology 36 (2): 123–133. doi:10.1159/000324710. PMID 21422765.
van den Berg, Bianca; Walgaard, Christa; Drenthen, Judith; Fokke, Christiaan; Jacobs, Bart C.; van Doorn, Pieter A. (15 July 2014). «Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis». Nature Reviews Neurology 10 (8): 469–482. doi:10.1038/nrneurol.2014.121. PMID 25023340.
van Doorn, Pieter A; Ruts, Liselotte; Jacobs, Bart C (October 2008). «Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome». The Lancet Neurology 7 (10): 939–950. doi:10.1016/S1474-4422(08)70215-1. PMID 18848313.
«Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification». Autoimmunity Reviews 13 (4–5): 525–30. April 2014. doi:10.1016/j.autrev.2014.01.033. PMID 24434363.
Willison, Hugh J; Jacobs, Bart C; van Doorn, Pieter A (March 2016). «Guillain–Barré syndrome». The Lancet 388 (Online first): 717–27. doi:10.1016/S0140-6736(16)00339-1. PMID 26948435.
Yuki, Nobuhiro; Hartung, Hans-Peter (14 June 2012). «Guillain–Barré Syndrome». New England Journal of Medicine 366 (24): 2294–2304. doi:10.1056/NEJMra1114525. PMID 22694000. https://archive.org/details/sim_new-england-journal-of-medicine_2012-06-14_366_24/page/2294.
Shahrizaila, N.; Yuki, N. (15 September 2012). «Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome». Journal of Neurology, Neurosurgery & Psychiatry 84 (5): 576–583. doi:10.1136/jnnp-2012-302824. PMID 22984203.
Ryan, Monique M. (December 2013). «Pediatric Guillain–Barré syndrome». Current Opinion in Pediatrics 25 (6): 689–693. doi:10.1097/MOP.0b013e328365ad3f. PMID 24240288.
«IVIG treatment and prognosis in Guillain–Barré syndrome». Journal of Clinical Immunology 30 Suppl 1: S74–8. May 2010. doi:10.1007/s10875-010-9407-4. PMID 20396937.
«Neurological complications of dengue virus infection». The Lancet Neurology 12 (9): 906–19. September 2013. doi:10.1016/S1474-4422(13)70150-9. PMID 23948177.
Kohl, Alain; Gatherer, Derek (18 December 2015). «Zika virus: a previously slow pandemic spreads rapidly through the Americas». Journal of General Virology 97 (2): 269–73. doi:10.1099/jgv.0.000381. PMID 26684466. http://eprints.gla.ac.uk/113711/1/113711.pdf.
«Guillain–Barré syndrome after exposure to influenza virus». The Lancet Infectious Diseases 10 (9): 643–51. Sep 2010. doi:10.1016/S1473-3099(10)70140-7. PMID 20797646.
Rinaldi, Simon (June 2013). «Update on Guillain–Barré syndrome». Journal of the Peripheral Nervous System 18 (2): 99–112. doi:10.1111/jns5.12020. PMID 23781958.
DeStefano, F; Bodenstab, HM; Offit, PA (February 2019). «Principal Controversies in Vaccine Safety in the United States». Clinical Infectious Diseases 69 (4): 726–731. doi:10.1093/cid/ciz135. PMID 30753348.
«Axonal Guillain–Barré syndrome: concepts and controversies». The Lancet Neurology 12 (12): 1180–8. December 2013. doi:10.1016/S1474-4422(13)70215-1. PMID 24229616.
Willison, Hugh J.; Goodyear, Carl S. (September 2013). «Glycolipid antigens and autoantibodies in autoimmune neuropathies». Trends in Immunology 34 (9): 453–459. doi:10.1016/j.it.2013.05.001. PMID 23770405.
«Clinical practice guideline on diagnosis and treatment of hyponatraemia». European Journal of Endocrinology 170 (3): G1–47. 25 Feb 2014. doi:10.1530/EJE-13-1020. PMID 24569125.
Ropper, Allan H. (April 23, 1992). «Current Concepts - The Guillain–Barré Syndrome». New England Journal of Medicine 326 (17): 1130–1136. doi:10.1056/NEJM199204233261706. PMID 1552914. https://archive.org/details/sim_new-england-journal-of-medicine_1992-04-23_326_17/page/1130.
«Electrodiagnostic criteria for Guillain–Barrè syndrome: a critical revision and the need for an update». Clinical Neurophysiology 123 (8): 1487–95. August 2012. doi:10.1016/j.clinph.2012.01.025. PMID 22480600.
Hughes, RA; Swan, AV; van Doorn, PA (Sep 19, 2014). «Intravenous immunoglobulin for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 9 (9): CD002063. doi:10.1002/14651858.CD002063.pub6. PMID 25238327.
«Practice parameter: immunotherapy for Guillain–Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology». Neurology 61 (6): 736–40. September 2003. doi:10.1212/WNL.61.6.736. PMID 14504313.
Dantal J (October 2013). «Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk». American Journal of Nephrology 38 (4): 275–84. doi:10.1159/000354893. PMID 24051350.
Hughes, RA; van Doorn, PA (15 August 2012). «Corticosteroids for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 8 (8): CD001446. doi:10.1002/14651858.CD001446.pub4. PMID 22895921.
«Guillain–Barré syndrome and variants». Neurology Clinics 31 (2): 491–510. May 2013. doi:10.1016/j.ncl.2013.01.005. PMID 23642721.
Liu, J; Wang, LN; McNicol, ED (20 October 2013). «Pharmacological treatment for pain in Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 10 (10): CD009950. doi:10.1002/14651858.CD009950.pub2. PMID 24142399.
Khan, F; Ng, L; Amatya, B; Brand, C; Turner-Stokes, L (6 October 2010). «Multidisciplinary care for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews (10): CD008505. doi:10.1002/14651858.CD008505.pub2. PMID 20927774.
«Immunotherapy for Guillain–Barré syndrome: a systematic review». Brain 130 (Pt 9): 2245–57. Sep 2007. doi:10.1093/brain/awm004. PMID 17337484. Αρχειοθετήθηκε από το πρωτότυπο στις 2014-10-29. https://web.archive.org/web/20141029153709/http://brain.oxfordjournals.org/content/130/9/2245.
Darweesh, Sirwan K. L.; Polinder, Suzanne; Mulder, Maxim J. H. L.; Baena, Cristina P.; van Leeuwen, Nikki; Franco, Oscar H.; Jacobs, Bart C.; van Doorn, Pieter A. (March 2014). «Health-related quality of life in Guillain–Barré syndrome patients: a systematic review». Journal of the Peripheral Nervous System 19 (1): 24–35. doi:10.1111/jns5.12051. PMID 24456426.
Fisher M (1956). «An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmolplegia, ataxia and areflexia)». N. Engl. J. Med. 255 (2): 57–65. doi:10.1056/NEJM195607122550201. PMID 13334797.
Bickerstaff, E.R.; Cloake, P.C. (14 July 1951). «Mesencephalitis and rhombencephalitis.». British Medical Journal 2 (4723): 77–81. doi:10.1136/bmj.2.4723.77. PMID 14848512. PMC 2069534. https://archive.org/details/sim_british-medical-journal_1951-07-14_2_4723/page/77.
Bickerstaff, E.R. (15 June 1957). «Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis.». British Medical Journal 1 (5032): 1384–7. doi:10.1136/bmj.1.5032.1384. PMID 13436795.
Asbury, Arthur K.; Cornblath, David R. (1990). «Assessment of current diagnostic criteria for Guillain–Barré syndrome.». Annals of Neurology 27 Suppl: S21–4. doi:10.1002/ana.410270707. PMID 2194422.
Sejvar, James J.; Kohl, Katrin S.; Gidudu, Jane; Amato, Anthony; Bakshi, Nandini; Baxter, Roger; Burwen, Dale R.; Cornblath, David R. και άλλοι. (January 2011). «Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data». Vaccine 29 (3): 599–612. doi:10.1016/j.vaccine.2010.06.003. PMID 20600491. https://zenodo.org/record/1259431.
Walgaard, Christa; Jacobs, Bart C; van Doorn, Pieter A (March 2011). «Emerging drugs for Guillain–Barré syndrome». Expert Opinion on Emerging Drugs 16 (1): 105–120. doi:10.1517/14728214.2011.531699. PMID 21352072.

gla.ac.uk

eprints.gla.ac.uk

Kohl, Alain; Gatherer, Derek (18 December 2015). «Zika virus: a previously slow pandemic spreads rapidly through the Americas». Journal of General Virology 97 (2): 269–73. doi:10.1099/jgv.0.000381. PMID 26684466. http://eprints.gla.ac.uk/113711/1/113711.pdf.

google.ca

books.google.ca

Ferri, Fred F. (2016). Ferri's Clinical Advisor 2017: 5 Books in 1 (στα Αγγλικά). Elsevier Health Sciences. σελ. 529. ISBN 9780323448383. Αρχειοθετήθηκε από το πρωτότυπο στις 21 Αυγούστου 2016.

hrsa.gov

«Vaccine Injury Table - HRSA» (PDF). HRSA. 22 Μαρτίου 2017. Ανακτήθηκε στις 23 Οκτωβρίου 2019.
«National Vaccine Injury Compensation Program». www.hrsa.gov (στα Αγγλικά). 11 Μαΐου 2017. Ανακτήθηκε στις 24 Οκτωβρίου 2019.

minervamedica.it

Khan, F.; Amatya, B. (September 2012). «Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review.». European Journal of Physical and Rehabilitation Medicine 48 (3): 507–22. PMID 22820829. Αρχειοθετήθηκε από το πρωτότυπο στις 2015-08-26. https://web.archive.org/web/20150826223515/http://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2012N03A0507.

nih.gov

ncbi.nlm.nih.gov

Sejvar, James J.; Baughman, Andrew L.; Wise, Matthew; Morgan, Oliver W. (2011). «Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis». Neuroepidemiology 36 (2): 123–133. doi:10.1159/000324710. PMID 21422765.
van den Berg, Bianca; Walgaard, Christa; Drenthen, Judith; Fokke, Christiaan; Jacobs, Bart C.; van Doorn, Pieter A. (15 July 2014). «Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis». Nature Reviews Neurology 10 (8): 469–482. doi:10.1038/nrneurol.2014.121. PMID 25023340.
van Doorn, Pieter A; Ruts, Liselotte; Jacobs, Bart C (October 2008). «Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome». The Lancet Neurology 7 (10): 939–950. doi:10.1016/S1474-4422(08)70215-1. PMID 18848313.
«Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification». Autoimmunity Reviews 13 (4–5): 525–30. April 2014. doi:10.1016/j.autrev.2014.01.033. PMID 24434363.
Willison, Hugh J; Jacobs, Bart C; van Doorn, Pieter A (March 2016). «Guillain–Barré syndrome». The Lancet 388 (Online first): 717–27. doi:10.1016/S0140-6736(16)00339-1. PMID 26948435.
Yuki, Nobuhiro; Hartung, Hans-Peter (14 June 2012). «Guillain–Barré Syndrome». New England Journal of Medicine 366 (24): 2294–2304. doi:10.1056/NEJMra1114525. PMID 22694000. https://archive.org/details/sim_new-england-journal-of-medicine_2012-06-14_366_24/page/2294.
Shahrizaila, N.; Yuki, N. (15 September 2012). «Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome». Journal of Neurology, Neurosurgery & Psychiatry 84 (5): 576–583. doi:10.1136/jnnp-2012-302824. PMID 22984203.
Ryan, Monique M. (December 2013). «Pediatric Guillain–Barré syndrome». Current Opinion in Pediatrics 25 (6): 689–693. doi:10.1097/MOP.0b013e328365ad3f. PMID 24240288.
«IVIG treatment and prognosis in Guillain–Barré syndrome». Journal of Clinical Immunology 30 Suppl 1: S74–8. May 2010. doi:10.1007/s10875-010-9407-4. PMID 20396937.
«Neurological complications of dengue virus infection». The Lancet Neurology 12 (9): 906–19. September 2013. doi:10.1016/S1474-4422(13)70150-9. PMID 23948177.
Kohl, Alain; Gatherer, Derek (18 December 2015). «Zika virus: a previously slow pandemic spreads rapidly through the Americas». Journal of General Virology 97 (2): 269–73. doi:10.1099/jgv.0.000381. PMID 26684466. http://eprints.gla.ac.uk/113711/1/113711.pdf.
«Guillain–Barré syndrome after exposure to influenza virus». The Lancet Infectious Diseases 10 (9): 643–51. Sep 2010. doi:10.1016/S1473-3099(10)70140-7. PMID 20797646.
Rinaldi, Simon (June 2013). «Update on Guillain–Barré syndrome». Journal of the Peripheral Nervous System 18 (2): 99–112. doi:10.1111/jns5.12020. PMID 23781958.
DeStefano, F; Bodenstab, HM; Offit, PA (February 2019). «Principal Controversies in Vaccine Safety in the United States». Clinical Infectious Diseases 69 (4): 726–731. doi:10.1093/cid/ciz135. PMID 30753348.
«Axonal Guillain–Barré syndrome: concepts and controversies». The Lancet Neurology 12 (12): 1180–8. December 2013. doi:10.1016/S1474-4422(13)70215-1. PMID 24229616.
Willison, Hugh J.; Goodyear, Carl S. (September 2013). «Glycolipid antigens and autoantibodies in autoimmune neuropathies». Trends in Immunology 34 (9): 453–459. doi:10.1016/j.it.2013.05.001. PMID 23770405.
«Clinical practice guideline on diagnosis and treatment of hyponatraemia». European Journal of Endocrinology 170 (3): G1–47. 25 Feb 2014. doi:10.1530/EJE-13-1020. PMID 24569125.
Ropper, Allan H. (April 23, 1992). «Current Concepts - The Guillain–Barré Syndrome». New England Journal of Medicine 326 (17): 1130–1136. doi:10.1056/NEJM199204233261706. PMID 1552914. https://archive.org/details/sim_new-england-journal-of-medicine_1992-04-23_326_17/page/1130.
«Electrodiagnostic criteria for Guillain–Barrè syndrome: a critical revision and the need for an update». Clinical Neurophysiology 123 (8): 1487–95. August 2012. doi:10.1016/j.clinph.2012.01.025. PMID 22480600.
Hughes, RA; Swan, AV; van Doorn, PA (Sep 19, 2014). «Intravenous immunoglobulin for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 9 (9): CD002063. doi:10.1002/14651858.CD002063.pub6. PMID 25238327.
«Practice parameter: immunotherapy for Guillain–Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology». Neurology 61 (6): 736–40. September 2003. doi:10.1212/WNL.61.6.736. PMID 14504313.
Dantal J (October 2013). «Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk». American Journal of Nephrology 38 (4): 275–84. doi:10.1159/000354893. PMID 24051350.
Hughes, RA; van Doorn, PA (15 August 2012). «Corticosteroids for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 8 (8): CD001446. doi:10.1002/14651858.CD001446.pub4. PMID 22895921.
«Guillain–Barré syndrome and variants». Neurology Clinics 31 (2): 491–510. May 2013. doi:10.1016/j.ncl.2013.01.005. PMID 23642721.
Liu, J; Wang, LN; McNicol, ED (20 October 2013). «Pharmacological treatment for pain in Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 10 (10): CD009950. doi:10.1002/14651858.CD009950.pub2. PMID 24142399.
Khan, F.; Amatya, B. (September 2012). «Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review.». European Journal of Physical and Rehabilitation Medicine 48 (3): 507–22. PMID 22820829. Αρχειοθετήθηκε από το πρωτότυπο στις 2015-08-26. https://web.archive.org/web/20150826223515/http://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2012N03A0507.
Khan, F; Ng, L; Amatya, B; Brand, C; Turner-Stokes, L (6 October 2010). «Multidisciplinary care for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews (10): CD008505. doi:10.1002/14651858.CD008505.pub2. PMID 20927774.
«Immunotherapy for Guillain–Barré syndrome: a systematic review». Brain 130 (Pt 9): 2245–57. Sep 2007. doi:10.1093/brain/awm004. PMID 17337484. Αρχειοθετήθηκε από το πρωτότυπο στις 2014-10-29. https://web.archive.org/web/20141029153709/http://brain.oxfordjournals.org/content/130/9/2245.
Darweesh, Sirwan K. L.; Polinder, Suzanne; Mulder, Maxim J. H. L.; Baena, Cristina P.; van Leeuwen, Nikki; Franco, Oscar H.; Jacobs, Bart C.; van Doorn, Pieter A. (March 2014). «Health-related quality of life in Guillain–Barré syndrome patients: a systematic review». Journal of the Peripheral Nervous System 19 (1): 24–35. doi:10.1111/jns5.12051. PMID 24456426.
Fisher M (1956). «An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmolplegia, ataxia and areflexia)». N. Engl. J. Med. 255 (2): 57–65. doi:10.1056/NEJM195607122550201. PMID 13334797.
Bickerstaff, E.R.; Cloake, P.C. (14 July 1951). «Mesencephalitis and rhombencephalitis.». British Medical Journal 2 (4723): 77–81. doi:10.1136/bmj.2.4723.77. PMID 14848512. PMC 2069534. https://archive.org/details/sim_british-medical-journal_1951-07-14_2_4723/page/77.
Bickerstaff, E.R. (15 June 1957). «Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis.». British Medical Journal 1 (5032): 1384–7. doi:10.1136/bmj.1.5032.1384. PMID 13436795.
Asbury, Arthur K.; Cornblath, David R. (1990). «Assessment of current diagnostic criteria for Guillain–Barré syndrome.». Annals of Neurology 27 Suppl: S21–4. doi:10.1002/ana.410270707. PMID 2194422.
Sejvar, James J.; Kohl, Katrin S.; Gidudu, Jane; Amato, Anthony; Bakshi, Nandini; Baxter, Roger; Burwen, Dale R.; Cornblath, David R. και άλλοι. (January 2011). «Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data». Vaccine 29 (3): 599–612. doi:10.1016/j.vaccine.2010.06.003. PMID 20600491. https://zenodo.org/record/1259431.
Walgaard, Christa; Jacobs, Bart C; van Doorn, Pieter A (March 2011). «Emerging drugs for Guillain–Barré syndrome». Expert Opinion on Emerging Drugs 16 (1): 105–120. doi:10.1517/14728214.2011.531699. PMID 21352072.

pubmedcentral.nih.gov

Sejvar, James J.; Baughman, Andrew L.; Wise, Matthew; Morgan, Oliver W. (2011). «Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis». Neuroepidemiology 36 (2): 123–133. doi:10.1159/000324710. PMID 21422765.
«IVIG treatment and prognosis in Guillain–Barré syndrome». Journal of Clinical Immunology 30 Suppl 1: S74–8. May 2010. doi:10.1007/s10875-010-9407-4. PMID 20396937.
Hughes, RA; Swan, AV; van Doorn, PA (Sep 19, 2014). «Intravenous immunoglobulin for Guillain–Barré syndrome.». The Cochrane Database of Systematic Reviews 9 (9): CD002063. doi:10.1002/14651858.CD002063.pub6. PMID 25238327.
«Guillain–Barré syndrome and variants». Neurology Clinics 31 (2): 491–510. May 2013. doi:10.1016/j.ncl.2013.01.005. PMID 23642721.
Bickerstaff, E.R.; Cloake, P.C. (14 July 1951). «Mesencephalitis and rhombencephalitis.». British Medical Journal 2 (4723): 77–81. doi:10.1136/bmj.2.4723.77. PMID 14848512. PMC 2069534. https://archive.org/details/sim_british-medical-journal_1951-07-14_2_4723/page/77.
Bickerstaff, E.R. (15 June 1957). «Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis.». British Medical Journal 1 (5032): 1384–7. doi:10.1136/bmj.1.5032.1384. PMID 13436795.

ninds.nih.gov

«Guillain–Barré Syndrome Fact Sheet». NIAMS. 1 Ιουνίου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 5 Αυγούστου 2016. Ανακτήθηκε στις 13 Αυγούστου 2016.

oxfordjournals.org

brain.oxfordjournals.org

«Immunotherapy for Guillain–Barré syndrome: a systematic review». Brain 130 (Pt 9): 2245–57. Sep 2007. doi:10.1093/brain/awm004. PMID 17337484. Αρχειοθετήθηκε από το πρωτότυπο στις 2014-10-29. https://web.archive.org/web/20141029153709/http://brain.oxfordjournals.org/content/130/9/2245.

web.archive.org

«Guillain–Barré Syndrome Fact Sheet». NIAMS. 1 Ιουνίου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 5 Αυγούστου 2016. Ανακτήθηκε στις 13 Αυγούστου 2016.
Ferri, Fred F. (2016). Ferri's Clinical Advisor 2017: 5 Books in 1 (στα Αγγλικά). Elsevier Health Sciences. σελ. 529. ISBN 9780323448383. Αρχειοθετήθηκε από το πρωτότυπο στις 21 Αυγούστου 2016.
Khan, F.; Amatya, B. (September 2012). «Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review.». European Journal of Physical and Rehabilitation Medicine 48 (3): 507–22. PMID 22820829. Αρχειοθετήθηκε από το πρωτότυπο στις 2015-08-26. https://web.archive.org/web/20150826223515/http://www.minervamedica.it/en/journals/europa-medicophysica/article.php?cod=R33Y2012N03A0507.
«Immunotherapy for Guillain–Barré syndrome: a systematic review». Brain 130 (Pt 9): 2245–57. Sep 2007. doi:10.1093/brain/awm004. PMID 17337484. Αρχειοθετήθηκε από το πρωτότυπο στις 2014-10-29. https://web.archive.org/web/20141029153709/http://brain.oxfordjournals.org/content/130/9/2245.
Landry, Jean-Baptiste (1859). «Note sur la paralysie ascendante aiguë». Gazette Hebdomadaire de Médecine et de Chirurgie 6: 472–474, 486–488. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-02-27. https://web.archive.org/web/20170227205021/https://books.google.com/books?id=rwxAAAAAcAAJ&pg=PA486.

zenodo.org

Sejvar, James J.; Kohl, Katrin S.; Gidudu, Jane; Amato, Anthony; Bakshi, Nandini; Baxter, Roger; Burwen, Dale R.; Cornblath, David R. και άλλοι. (January 2011). «Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data». Vaccine 29 (3): 599–612. doi:10.1016/j.vaccine.2010.06.003. PMID 20600491. https://zenodo.org/record/1259431.